Journal of Affective Disorders
Volume 82, Issue 1 , Pages 77-84 , 1 October 2004

Use of prescription medications and complementary and alternative medicines to treat depressive and anxiety symptoms: results from a community sample

Received 22 May 2003 ,Revised 29 September 2003 ,Accepted 29 September 2003.

References 

  1. Andrews G, Hunt C. Treatments that work in anxiety disorders. Med. J. Aust. 1998;168:628–634
  2. Angermeyer MC, Matschinger H. Public attitude towards psychiatric treatment. Acta Psychiatr. Scand. 1996;94:326–336
  3. Astin JA. Why patients use alternative medicine. Results of a national study. J. Am. Med. Assoc. 1998;9:1548–1553
  4. Australian Bureau of Statistics, 1999. National health survey: use of medications Australia 1995. ABS Catalogue no. 4377.0, Canberra, ABS.
  5. Barrett B. Complementary and alternative medicine. West. Med. J. 2001;100:20–26
  6. Benkert O, Graf-Morgenstern M, Hillert A, Sandmann J, Ehmig SC, Weissbecker H, et al. Public opinion on psychotropic drugs: an analysis of the factors influencing acceptance or rejection. J. Nerv. Ment. Dis. 1997;185:151–158
  7. Bensoussan A. Complementary medicine—wherein lies its appeal?. Med. J. Aust. 1999;170:247–248
  8. De Smet PAGM. Should herbal medicine-like products be licensed as medicines?. Br. Med. J. 1995;310:1023–1024
  9. Drew AK, Myers SP. Safety issues in herbal medicine: implications for the health professions. Med. J. Aust. 1997;166:538–541
  10. Eisenberg L. Complementary and alternative medicine: what is its role?. Harv. Rev. Psychiatry. 2002;10:221–230
  11. Ernst E. The risk-benefit profile of commonly used herbal therapies: ginkgo, St John's wort, ginseng, echinacea, saw palmetto and kava. Ann. Intern. Med. 2002;136:42–53
  12. Eysenck SBG, Eysenck HJ, Barrett P. A revised version of the psychoticism scale. Pers. Indiv. Diff. 1985;6:21–29
  13. Goldberg DP, Bridges K, Duncan-Jones P, Grayson D. Detecting anxiety and depression in general medical settings. Br. Med. J. 1988;297:897–899
  14. Hickie IB. An approach to managing depression in general practice. Med. J. Aust. 2000;173:106–110
  15. Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs. 2001;61:2163–2175
  16. Jorm AF, Korten AE, Jacomb PA, Christensen H, Rodgers B, Pollitt P. “Mental health literacy”: a survey of the public's ability to recognize mental disorders and their beliefs about the effectiveness of treatment. Med. J. Aust. 1997;166:182–186
  17. Jorm AF, Christensen H, Griffiths KM, Rodgers B. Effectiveness of complementary and self-help treatments for depression. Med. J. Aust. 2002;176:S84–S96
  18. Kaptchuk TJ. Uptake of alternative medicine. Lancet. 1996;347:972
  19. Kessler RC, Soukup J, Davis RB, Foster DF, Wilkey SA, Van Rompay MI, et al. The use of complementary and alternative therapies to treat anxiety and depression in the United States. Am. J. Psychiatry. 2001;158:289–294
  20. Kisely S, Linden M, Bellantuono C, Simon G, Jones J. Why are patients prescribed psychotropic drugs by general practitioners? Results of an international study. Psychol. Med. 2000;30:1217–1225
  21. MacKinnon A. The interquartile odds ratio: a suggestion for the presentation of results from continuous predictors in logistic regression. Int. J. Method Psychiatr. Res. 1992;2:233–235
  22. MacLennan AH, Wilson DH, Taylor AW. Prevalence and cost of alternative medicine in Australia. Lancet. 1996;347:569–573
  23. MacLennan AH, Wilson DH, Taylor AW. The escalating cost and prevalence of alternative medicine. Prev. Med. 2002;35:166–173
  24. McFarland B, Bigelow D, Zani B, Newsom J, Kaplan M. Complementary and alternative medicine use in Canada and the United States. Am. J. Public Health. 2002;92:1616–1618
  25. McGregor KJ, Peay ER. The choice of alternative therapy for health care: testing some propositions. Soc. Sci. Med. 1996;43:1317–1327
  26. McManus P, Mant A, Mitchell PB, Montgomery WS, Marley J, Auland ME. Recent trends in the use of antidepressant drugs in Australia, 1990–1998. Med. J. Aust. 2000;173:458–461
  27. MediMedia Australia Pty. Ltd. . EMIMS Version 4.000604. Sydney: MediMedia Australia; 2002;
  28. Ohayon MM, Lader MH. Use of psychotropic medication in the general population of France, Germany, Italy and the United Kingdom. J. Clin. Psychiatry. 2002;63:817–825
  29. Ohayon MM, Caulet M, Priest RG, Guilleminault C. Psychotropic medication consumption patterns in the UK general population. J. Clin. Epidemiol. 1998;51:273–283
  30. Parslow RA, Jorm AF. Predictors of types of help provided to people using services for mental health problems: an analysis of the Australian national survey of mental health and wellbeing. Aust. New Zealand J. Psychiatry. 2001;35:183–189
  31. Pearlin LI, Menaghan EG, Lieberman MA, Mullan JT. The stress process. J. Health Soc. Behav. 1981;22:337–356
  32. Pies R. Adverse neuropsychiatric reactions to herbal and over-the-counter “antidepressants”. J. Clin. Psychiatry. 2000;61:815–820
  33. Punamaki RL, Aschan H. Self-care and mastery among primary health care patients. Soc. Sci. Med. 1994;39:733–741
  34. Siahpush M. Why do people favour alternative medicine?. Aust. New Zealand J. Public Health. 1999;23:266–271
  35. Stevinson C, Huntley A, Ernst E. A systematic review of the safety of kava extract in the treatment of anxiety. Drug Saf. 2002;25:251–261
  36. Unutzer J, Klap R, Sturm R, Young AS, Marmot T, Shatkin J, et al. Mental disorders and the use of alternative medicine: results from a national survey. Am. J. Psychiatry. 2000;157:1851–1857
  37. Wang JL, Patten SB, Russell ML. Alternative medicine use by individuals with major depression. Can. J. Psychiatry. 2001;46:528–533
  38. Ware JE, Kosinski M, Keller SD. A 12-item short form health survey. Med. Care. 1996;34:220–233
  39. Wilkinson JM, Simpson MD. High use of complementary therapies in a New South Wales rural community. Aust. J. Rural Health. 2001;9:166–171

PII: S0165-0327(03)00267-2

doi: 10.1016/j.jad.2003.09.013

Journal of Affective Disorders
Volume 82, Issue 1 , Pages 77-84 , 1 October 2004